Sunrest Lifescience Ltd

Sunrest Lifescience Board Meeting Outcome

Sunrest Lifescience Limited has cancelled its Rights Issue due to the non-receipt of the minimum subscription required by SEBI regulations.

Sunrest Lifescience Annual General Meeting

Sunrest Lifescience held its 9th AGM on 7 Sep 2026 via VC/OAVM. Resolutions covered adoption of FY26 financials, re-appointment of MD and WTD, and related-party transaction approval.

Sunrest Lifescience Capital Structure Change

Sunrest Lifescience Limited has extended its ongoing Rights Issue by nine days, with the new closing date set for September 11, 2026.

Sunrest Lifescience Business Update

Sunrest Lifescience Limited's subsidiary, Hetvi Lifesciences, is executing a ₹9.22 Crore order from Gujarat Medical Services Corporation Limited. ₹80.76 Lakhs worth of work is completed.

Value

₹9.22 Cr

Sunrest Lifescience Annual General Meeting

Sunrest Lifescience Limited has issued a notice for its Annual General Meeting scheduled for September 7, 2026, to transact various ordinary and special businesses.

Value

₹10.00 Cr

Sunrest Lifescience Annual General Meeting

Sunrest Lifescience Limited will hold its Annual General Meeting on September 07, 2026. The company has also filed its Annual Report for the financial year 2025-26.

Sunrest Lifescience Board Meeting Outcome

Sunrest Lifescience's Board approved the 9th AGM notice and cut-off dates. The Board also approved director re-appointments and material related party transactions.

Sunrest Lifescience Board Meeting Date

Sunrest Lifescience Limited has scheduled a board meeting for August 12, 2026. The meeting will address general business matters.

Sunrest Lifescience Capital Structure Change

Sunrest Lifescience Limited has fixed August 10, 2026, as the record date for its 1:1 rights issue. Eligible shareholders will receive one equity share for every share held.

Sunrest Lifescience Capital Structure Change

Sunrest Lifescience Limited announced a Rights Issue of 42,91,200 equity shares at Rs.35 per share, totaling Rs.15.02 Crore. The issue opens on August 18, 2026.

Value

₹15.02 Cr

Sunrest Lifescience Board Meeting Date

Sunrest Lifescience rescheduled its board meeting to July 30, 2026. The meeting's agenda includes a fund raise via rights issue.

Sunrest Lifescience Board Meeting Date

Sunrest Lifescience rescheduled its board meeting to July 17, 2026. The meeting will consider a proposed rights issue for fund raising.

Sunrest Lifescience Board Meeting Date

Sunrest Lifescience rescheduled its board meeting to July 10, 2026. The agenda includes a proposed fund raise via a rights issue.

Sunrest Lifescience Fund Raise of ₹15.1 Cr

Sunrest Lifescience approved raising up to ₹15.1 Crore through a rights issue of equity shares. The shares will be issued to eligible shareholders.

Value

₹15.10 Cr

Sunrest Lifescience Results Correction

Sunrest Lifescience is re-submitting revised financial results for March 31, 2025. This corrects discrepancies previously identified by the exchange.

Sunrest Lifescience Other Announcement

Sunrest Lifescience Limited confirmed it is not identified as a Large Corporate for FY 2025-26. This filing ensures compliance with SEBI's debt-raising framework for large entities.

Sunrest Lifescience Other Announcement

Sunrest Lifescience clarified the non-applicability of Annual Secretarial Compliance Report requirements due to its SME Exchange listing status. This confirms regulatory compliance with SEBI LODR exemptions.

Sunrest Lifescience Management Change

Sunrest Lifescience Limited appointed M/s. VRCA & ASSOCIATES as Internal Auditor for a 12-month term. This ensures continued regulatory compliance and internal financial oversight.

Execution

12 months

Sunrest Lifescience H2 FY26 Results: Net Profit ₹3.4 Cr, Up 70.0% YoY

Sunrest Lifescience Ltd reported revenue from operations of ₹36.8 Cr (+10.2% YoY) and net profit of ₹3.4 Cr (+70.0% YoY) for H2 FY26.

Key figure

Net profit ₹3.4 Cr · +70.0% YoY

Sunrest Lifescience Financial Results

Sunrest Lifescience Limited reported its audited financial results for the year ended March 31, 2026. The company also announced the appointment of internal auditors.

Sunrest Lifescience Board Meeting Date

Sunrest Lifescience Limited scheduled a board meeting on May 29, 2026, to approve audited annual financial results. The company's trading window remains closed until June 2026.

Sunrest Lifescience Other Announcement

Sunrest Lifescience Limited reconstituted its Audit and Stakeholders Relationship Committees effective May 14, 2026. This administrative update ensures ongoing compliance with board governance regulations.

Sunrest Lifescience Board Meeting Outcome

Sunrest Lifescience Limited has decided to dissolve its rights issue, which was open from April 2 to April 30, 2026. The board cancelled the issue due to non-receipt of minimum subscription. Consequently, the company will unblock funds for all applicants as per SEBI regulations.

Sunrest Lifescience Other Announcement

Sunrest Lifescience Limited submitted a compliance exemption filing for the quarter ended March 31, 2026. As an SME-listed entity with paid-up capital below ₹10 Crore and net worth below ₹25 Crore, it is exempt from mandatory Corporate Governance Report submissions under SEBI LODR Regulation 15(2).

Sunrest Lifescience Other Announcement

Sunrest Lifescience Limited submitted a certificate confirming the non-applicability of Related Party Disclosure requirements under SEBI Regulation 23. As an NSE Emerge listed SME with paid-up capital below ₹10 Crore and net worth below ₹25 Crore, the company is exempt from these corporate governance provisions for the financial year ended March 31, 2026.

Sunrest Lifescience Other Announcement

Sunrest Lifescience Limited submitted its Structured Digital Database (SDD) Compliance Certificate for the quarter ended March 31, 2026. The Managing Director certified that the company maintains an internal, non-tamperable database to track unpublished price sensitive information (UPSI) as per SEBI regulations.